WA
XBI icon

WP Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

WP Advisors’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,613
Closed -$212K – 118
2025
Q1 		$212K Hold
2,613
– – 0.07% 107
2024
Q4 		$235K Sell
2,613
-479
-15% -$46.4K 0.08% 95
2024
Q3 		$305K Sell
3,092
-10,452
-77% -$1.03M 0.11% 83
2024
Q2 		$1.26M Sell
13,544
-2,927
-18% -$262K 0.4% 47
2024
Q1 		$1.56M Sell
16,471
-284
-2% -$26.4K 0.51% 40
2023
Q4 		$1.5M Buy
16,755
+4,068
+32% +$302K 0.55% 39
2023
Q3 		$926K Buy
12,687
+303
+2% +$24.2K 0.38% 48
2023
Q2 		$1.03M Sell
12,384
-20
-0.2% -$1.67K 0.41% 46
2023
Q1 		$945K Sell
12,404
-1,612
-12% -$134K 0.39% 52
2022
Q4 		$1.16M Sell
14,016
-5,625
-29% -$455K 0.52% 43
2022
Q3 		$1.56M Hold
19,641
– – 0.71% 33
2022
Q2 		$1.46M Buy
19,641
+986
+5% +$74K 0.63% 37
2022
Q1 		$1.68M Buy
18,655
+6,380
+52% +$589K 0.69% 33
2021
Q4 		$1.37M Sell
12,275
-1,376
-10% -$166K 0.57% 41
2021
Q3 		$1.72M Buy
13,651
+9,357
+218% +$1.2M 0.7% 29
2021
Q2 		$581K Hold
4,294
– – 0.24% 65
2021
Q1 		$583K Sell
4,294
-2,472
-37% -$370K 0.25% 59
2020
Q4 		$953K Buy
6,766
+8
+0.1% +$1.02K 0.46% 41
2020
Q3 		$753K Buy
6,758
+5
+0.1% +$561 0.45% 41
2020
Q2 		$756K Buy
6,753
+1
+0% +$98 0.53% 29
2020
Q1 		$523K Hold
6,752
– – 0.51% 23
2019
Q4 		$642K Buy
6,752
+154
+2% +$13.3K 0.66% 26
2019
Q3 		$503K Buy
6,598
+786
+14% +$65.3K 0.58% 28
2019
Q2 		$510K Buy
5,812
+4,512
+347% +$385K 0.57% 29
2019
Q1 		$1.18K Buy
+1,300
New +$111K 0.13% 76
2018
Q4 		– Sell
-1,300
Closed -$125K – 239
2018
Q3 		$125K Sell
1,300
-100
-7% -$9.7K 0.12% 77
2018
Q2 		$133K Buy
+1,400
New +$129K 0.13% 74

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $134M AUM 21.11% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

WP Advisors's XBI Position: Q2 2025 in Review

WP Advisors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2025, closing a stake of 2,613 shares — an estimated $212K sold.

WP Advisors first reported a position in XBI in Q2 2018 and held it in 27 quarters. The position peaked at $1.72M in Q3 2021. 625 funds tracked by Wall St. Rank hold XBI as of Q2 2025.

  • WP Advisors reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2025 after selling out during the quarter.
  • WP Advisors sold 2,613 State Street SPDR S&P Biotech ETF shares in Q2 2025, an estimated $212K.
  • WP Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q2 2018 and held it in 27 quarters.
  • WP Advisors's State Street SPDR S&P Biotech ETF position peaked at $1.72M in Q3 2021.
  • 625 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2025.

Based on WP Advisors's 13F filing for Q2 2025, filed 8 Aug 2025.